TL;DR
- •Veterinarians have among the highest occupational suicide rates of any profession — Tomasi 2019 (CDC) documented suicide mortality ratios roughly 2-3.5x higher than the general U.S. population, with female veterinarians at especially elevated risk.
- •Frequent euthanasia, client emotional intensity, debt-load relative to earnings, compassion fatigue, and "convenience euthanasia" moral injury create a stressor profile distinct from human medicine.
- •Telehealth ketamine therapy fits the veterinary schedule — sessions evenings or weekends, no clinic visits during practice hours, completely private from state board, AVMA, or employer animal hospital.
- •Tovani is direct-pay ($349/month, HSA/FSA eligible) — bypasses practice health plans and AVMA-affiliated insurance, keeping treatment outside professional-side records.
- •For veterinarians with DEA registration (most practicing vets), state veterinary board concerns and AVMA Wellbeing Committee awareness make the privacy considerations particularly important — see privacy section below.
- •Most veterinarian-patients say what mattered most was: a clinician who understood the euthanasia-frequency burden; clear answer on DEA and state board implications; same physician every visit; complete separation from practice records.
The stressors specific to your work
- •Frequent euthanasia — multiple times per week, often with grieving owners present
- •"Convenience euthanasia" requests creating moral injury distinct from clinical end-of-life care
- •High educational debt (often $200K+) relative to veterinarian earnings creating chronic financial stress
- •Client emotional intensity during pet illness, often projecting human grief onto the clinician
- •Compassion fatigue from sustained empathic engagement across both animals and humans
- •Access to lethal medications creating elevated suicide-method-availability concern
Why telehealth works for veterinarians
- •Sessions evenings or weekends — no need to take time off from practice
- •No clinic visits during practice hours — no interference with surgical schedule or appointments
- •Treatment in your own home — completely private from practice staff and clients
- •Same physician every visit — continuity outside the veterinary professional network
- •Compatible with on-call rotations (avoid sessions during call windows)
Privacy considerations
- •Tovani is direct-pay — no insurance claim tied to practice or AVMA-affiliated health plan.
- •Patient records are HIPAA-protected and never shared with state veterinary boards, DEA, AVMA, practice owners, or any regulatory body without your explicit written authorization.
- •State veterinary board disclosure rules vary, but most jurisdictions only require disclosure of conditions that impair fitness to practice — NOT the existence of treatment itself. Well-managed outpatient depression or anxiety treatment is generally not reportable.
- •For veterinarians with DEA registration, routine outpatient mental-health treatment that does not involve impaired-practice events or controlled-substance misuse is not a DEA-reportable event. If you have specific concerns about your DEA registration or a complicating history, consult a healthcare attorney before starting.
- •AVMA Wellbeing Committee and state Veterinary Health Programs (analogous to physician PHPs) are generally confidential resources NOT linked to disciplinary processes for routine treatment — but the structure varies by state. Verify the confidentiality posture of your state's program before engaging with it.
DEA / licensure-sensitive role
Your profession has specific board-disclosure considerations. Discuss with your physician during consultation. For state-specific guidance, contact your state’s professional-assistance program.
5-minute screening · Reviewed by a board-certified physician · FL & NJ · $349/month
Frequently asked
Will my state veterinary board find out?
Not from Tovani. We don't report routine outpatient mental-health treatment to any state veterinary board, DEA, or AVMA. Most state veterinary-board disclosure questions ask about conditions that impair fitness to practice, NOT the existence of treatment itself. Well-managed outpatient depression or anxiety treatment is generally not reportable. If you have specific concerns about your state's disclosure language, consult your state's Veterinary Health Program (typically confidential and separate from disciplinary processes) before disclosing anything to the board itself.
I have DEA registration for my practice. Does ketamine treatment affect that?
Routine outpatient mental-health treatment that doesn't involve impaired-practice events or controlled-substance misuse is not a DEA-reportable event. The DEA cares about your ability to securely handle controlled substances at your practice and prescribe responsibly — receiving treatment for depression doesn't affect either. If you have specific concerns or a complicating history (past DEA action, state board agreement), consult a healthcare attorney before starting.
I've done a euthanasia today and I can't shake it. Is this depression or just a hard day?
Both can be true. Acute distress after a difficult euthanasia is normal and proportionate; what matters clinically is whether the distress persists, accumulates, and starts impairing function (sleep, mood between cases, joy in clinical work, relationships). Compassion fatigue and clinical depression in veterinarians often coexist. If symptoms persist past a few weeks of normal recovery, formal evaluation is appropriate.
I have access to lethal medications at work. Is that a concern?
Yes — it's one of the documented risk factors that contribute to the elevated veterinary suicide rate. Honest conversation with your physician about access, current ideation, and any plans is essential before starting any treatment. Tovani screens for this at intake (Columbia Protocol). Treatment can proceed safely in most cases with appropriate safety planning; for higher-risk presentations, a higher level of care may be the right starting point before outpatient ketamine.
I've tried SSRIs through my GP and they didn't help much. What now?
After multiple SSRI trials without sufficient response, you meet the technical criteria for treatment-resistant depression. Ketamine's mechanism (NMDA receptor antagonism) is completely different from SSRIs, so prior failures don't predict ketamine response. Published response rates in treatment-resistant cases are 60-70% within hours of the first session. Practical advantage for clinicians: rapid onset means you can evaluate response before the next high-stakes clinical day.
References
- Tomasi SE et al. 2019, Journal of the American Veterinary Medical Association. CDC analysis of veterinarian suicide 1979-2015 documenting elevated suicide mortality ratios in veterinary medicine, particularly among female veterinarians — establishes the seriousness of the population-level mental-health need. PMID 30668293
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT showed 64% response in treatment-resistant depression — relevant for high-prevalence professions where standard SSRI trials are often inadequate. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine's rapid antidepressant effects — particularly valuable when professional responsibilities don't allow extended treatment trials. PMID 28249076